Literature DB >> 18436328

Anti-HBs positive occult hepatitis B virus carrier blood infectious in two transfusion recipients.

Snezna Levicnik-Stezinar1, Urska Rahne-Potokar, Daniel Candotti, Nico Lelie, Jean-Pierre Allain.   

Abstract

BACKGROUND/AIMS: Occult hepatitis B infection (OBI) in blood donations is not considered infectious when anti-HBs is present.
METHODS: Four months after transfusion of eight blood components during coronary arterial bypass surgery, a 59-year-old patient developed acute hepatitis B. A second 71-year-old patient transfused with a red cell concentrate (RCC) from one of these donations had early HBV infection 7 months post-transfusion. Samples were tested for HBV serological markers and HBV DNA was quantified and sequenced.
RESULTS: One implicated donation contained anti-HBc, anti-HBs (12 IU/L) and 180 IU/ml of HBV DNA. Previous and subsequent samples contained 3-10 times lower viral load and slightly variable anti-HBs. Two previous donations did not cause HBV infection. Recipients of the FFP and RCC from the index donation were both HBV infected and carried genotype D strains with sequences identical to the donor strain.
CONCLUSIONS: Despite anti-HBs, an OBI carrier transmitted HBV to two immunocompetent transfusion recipients.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18436328     DOI: 10.1016/j.jhep.2008.02.016

Source DB:  PubMed          Journal:  J Hepatol        ISSN: 0168-8278            Impact factor:   25.083


  38 in total

Review 1.  Occult hepatitis B: clinical implications and treatment decisions.

Authors:  Paul Schmeltzer; Kenneth E Sherman
Journal:  Dig Dis Sci       Date:  2010-10-07       Impact factor: 3.199

Review 2.  Diagnostic algorithm for HBV safe transfusion.

Authors:  Jean-Pierre Allain; Daniel Candotti
Journal:  Blood Transfus       Date:  2009-07       Impact factor: 3.443

3.  Criteria for hepatitis B virus screening and validation of blood components in Italy: the position of the SIMTI HBV working group.

Authors:  Claudio Velati; Laura Fomiatti; Lorella Baruffi; Vanessa Piccinini; Daniele Prati; Anna Reina; Andrea Lobbiani; Alessandro Zanetti; Luisa Romanò
Journal:  Blood Transfus       Date:  2011-07-21       Impact factor: 3.443

Review 4.  Occult hepatitis B virus infection and blood transfusion.

Authors:  Dong Hee Seo; Dong Hee Whang; Eun Young Song; Kyou Sup Han
Journal:  World J Hepatol       Date:  2015-03-27

Review 5.  Molecular virology in transfusion medicine laboratory.

Authors:  Daniel Candotti; Jean-Pierre Allain
Journal:  Blood Transfus       Date:  2012-12-21       Impact factor: 3.443

6.  Characterisation and follow-up study of occult hepatitis B virus infection in anti-HBc-positive qualified blood donors in southern China.

Authors:  Xianlin Ye; Tong Li; Xiaoxuan Xu; Peng Du; Jinfeng Zeng; Weigang Zhu; Baocheng Yang; Chengyao Li; Jean-Pierre Allain
Journal:  Blood Transfus       Date:  2016-05-17       Impact factor: 3.443

7.  Occult hepatitis B virus infection in ART-naive HIV-infected patients seen at a tertiary care centre in north India.

Authors:  Swati Gupta; Sarman Singh
Journal:  BMC Infect Dis       Date:  2010-03-07       Impact factor: 3.090

8.  Detection of hepatitis B virus DNA among accepted blood donors in Nanjing, China.

Authors:  Yong Liu; Ping Li; Cuiping Li; Jinyong Zhou; Chao Wu; Yi-Hua Zhou
Journal:  Virol J       Date:  2010-08-19       Impact factor: 4.099

9.  Occult hepatitis B viral infection among blood donors in South-Eastern Nigeria.

Authors:  Emmanuel Nna; Chinenye Mbamalu; Ifeoma Ekejindu
Journal:  Pathog Glob Health       Date:  2014-07-04       Impact factor: 2.894

Review 10.  Hepatitis B transmission by cell and tissue allografts: how safe is safe enough?

Authors:  Pilar Solves; Vicente Mirabet; Manuel Alvarez
Journal:  World J Gastroenterol       Date:  2014-06-21       Impact factor: 5.742

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.